![Chris Ogden](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chris Ogden
Director of Finance/CFO at
CYTOMX THERAPEUTICS, INC.
Net worth: 480 281 $ as of 30/06/2026
Profile
Chris Ogden is currently Chief Financial Officer, Secretary & Senior VP at CytomX Therapeutics, Inc. since 2021.
Former roles include Chief Financial Officer-Diabetes Division at Eli Lilly & Co. and Chief Financial Officer & Treasurer at Lilly del Caribe, Inc. Education includes an undergraduate degree from Wabash College and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 15/06/2026 | 128,075 ( 0.08% ) | 480 281 $ | 30/06/2026 |
Chris Ogden active positions
| Companies | Position | Start |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | Director of Finance/CFO | 21/09/2022 |
Former positions of Chris Ogden
| Companies | Position | End |
|---|---|---|
Lilly del Caribe, Inc.
 Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Director of Finance/CFO | - |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
Training of Chris Ogden
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Wabash College
 Wabash College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lilly del Caribe, Inc.
Lilly del Caribe, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Chris Ogden
Choose MarketScreener 
